Praxis Precision Medicines (PRAX) Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
By Chris Wack Praxis Precision Medicines said it has entered into an exclusive collaboration and license agreement with Tenacia Biotechnology (Shanghai) Co.,.
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 3,460,000 shares, a growth of 25.4% from the October 31st total of 2,760,000 shares. Based on an average trading volume of 737,900 shares, the short-interest […]
UNAUDITED SELECTED FINANCIAL DATA Reverse Stock Split On November 28, 2023, at 5:00 p.m., Eastern Time, Praxis Precision Medicines, Inc. effected a 1-for-15.
Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming Meetings sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.